| Price | 382.00 on 22-09-2025 at 14:30:03 |
|---|---|
| Change | -12.30 -3.12% |
| Buy | 389.70 |
| Sell | 374.30 |
| Last Trade: | Buy 117.00 at 382.85 |
| Day's Volume: | 52,159 |
| Last Close: | 394.30 |
| Open: | 390.45 |
| ISIN: | DK0060336014 |
| Day's Range | 382.00 - 390.45 |
| 52wk Range: | 369.75 - 487.25 |
| Market Capitalisation: | - |
| VWAP: | 385.73732 |
| Shares in Issue: | 465.60m |
Novonesis B Ord (0Q4U) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 117 | 382.85 | SI Trade |
15:18:40 - 22-Sep-25 |
| Buy* | 300 | 382.70 | SI Trade |
15:16:28 - 22-Sep-25 |
| Buy* | 135 | 382.60 | SI Trade |
15:12:25 - 22-Sep-25 |
| Buy* | 135 | 382.60 | SI Trade |
15:12:25 - 22-Sep-25 |
| Unknown* | 0 | 382.41683 | SI Trade Currency Conversion |
15:12:14 - 22-Sep-25 |
| Sell* | 2,602 | 381.80 | SI Trade |
15:10:23 - 22-Sep-25 |
| Sell* | 2,602 | 381.80 | SI Trade |
15:10:23 - 22-Sep-25 |
| Sell* | 5 | 382.05 | SI Trade |
15:07:38 - 22-Sep-25 |
| Sell* | 1,331 | 382.10 | SI Trade |
15:05:29 - 22-Sep-25 |
| Sell* | 1,446 | 382.95 | SI Trade |
15:04:03 - 22-Sep-25 |
Novonesis B Ord (0Q4U) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 9th Jul 2018 1:13 pm | GNW | Transactions under Novozymes’ stock buyback program |
| 2nd Jul 2018 12:28 pm | GNW | Transactions under Novozymes’ stock buyback program |
| 25th Jun 2018 11:14 am | GNW | Transactions under Novozymes’ stock buyback program |
| 18th Jun 2018 10:06 am | GNW | Transactions under Novozymes’ stock buyback program |
| 11th Jun 2018 11:59 am | GNW | Transactions under Novozymes’ stock buyback program |
| 4th Jun 2018 7:49 am | GNW | Transactions under Novozymes’ stock buyback program |
| 28th May 2018 9:34 am | GNW | Transactions under Novozymes’ stock buyback program |
| 22nd May 2018 12:20 pm | GNW | Transactions under Novozymes’ stock buyback program |
| 14th May 2018 12:21 pm | GNW | Transactions under Novozymes’ stock buyback program |
| 7th May 2018 12:54 pm | GNW | Transactions under Novozymes’ stock buyback program |
